PPARδ agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-03-04. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
=== Drug development === ITC can provide insights into drug development by charactering the affinity, selectivity, ligand-induced conformational changes, and drug partitioning into membranes. Binding affinity carries a huge importance in medicinal chemistry, as drugs need to bind to the protein effectively within a desired range. An exothermic binding process with a favorable enthalpy is considered a desirable characteristic for specific protein binders, as it indicates strong potential for optimization and high selectivity. However, determining enthalpy changes and optimization of thermodynamic parameters are hugely difficult when designing drugs. ITC troubleshoots this issue easily by deducing the binding affinity, enthalpic/entropic contributions and its binding stoichiometry.
However the combined treatment may include serious side effects so is presently only recommended when rituximab has not worked alone. Finally, plasmapheresis, which involves filtering blood to remove antibodies, may be useful in acute hemolytic crisis and before surgery requiring hypothermia, however its effect is only short term. Removing the spleen is not recommended for cold agglutinin disease. In addition, because severe cold agglutinin disease requires very high doses of corticosteroids (levels not considered safe), corticosteroid treatment is no longer a recommended treatment in severe cases. Several possible therapies have been reported in a few case reports to have successfully treated people who are not responding to the treatments listed above. However more studies need to be performed before the safety and effectiveness of these therapies can be determined. Sutimlimab (Enjaymo) was approved for medical use in the United States in February 2022.
=== Other === AMH production by the Sertoli cells of the testes remains high throughout childhood in males but declines to low levels during puberty and adult life. AMH has been shown to regulate production of sex hormones, and changing AMH levels (rising in females, falling in males) may be involved in the onset of puberty in both sexes. Functional AMH receptors have also been found to be expressed in neurons in the brains of embryonic mice, and are thought to play a role in sexually dimorphic brain development and consequent development of gender-specific behaviours. In a clade of Sebastes rockfishes in the Northwest Pacific Ocean, a duplicated copy of the AMH gene (called AMHY) is the master sex-determining gene. In vitro experiments demonstrate that the overexpression of AMHY causes female-to-male sex reversal in at least one species, S. schlegelii.
Sources: en.wikipedia.org
Those who have used topical corticosteroids over a prolonged period of time Those who have used corticosteroids to cover a large surface area Those with broken skin barrier or extensive abrasions Those who have recently undergone stress (such as illness, trauma, surgery) Children under the age of 12 HPA axis suppression is preventable by supplementation with glucocorticosteroids. If HPA axis suppression occurs, it is often reversed shortly after discontinuation of treatment.
These vascular risk factors lead to ischemia (poor blood supply) to a portion of the optic disc. The disc then swells, and in a crowded optic disc, this leads to compression and more ischemia. GLP-1 agonists, a class of medications which are used to treat diabetes and obesity, appear to significantly increase the risk of developing NAION; however, further research is needed to establish if the observed association is a causal relationship. Since both eyes tend to have a similar shape, the optometrist or ophthalmologist will look at the good eye to assess the anatomical predisposition. The unaffected eye has a 14.7% risk of NAION within five years. A number of uncontrolled single case or small number of patient reports have associated NAION with use of oral erectile dysfunction drugs.
Alfred Guillou Redfield (March 11, 1929 – July 24, 2019) was an American physicist and biochemist. In 1955 he published the Redfield relaxation theory, effectively moving the practice of NMR or Nuclear magnetic resonance from the realm of classical physics to the realm of semiclassical physics. He is known for the development of Redfield equation. He continued to find novel magnetic resonance applications to solve real-world problems throughout his life. Redfield earned degrees at Harvard College (BA 1950, Master's 1952) and the University of Illinois, Urbana-Champaign (Ph.D. 1953). As a postdoc, he worked with Nicolaas Bloembergen at Harvard, where he first published the Redfield relaxation theory. IBM Watson Scientific Computing Laboratory hired him in 1955 and he taught at Columbia. While there, he published his most important work, the Redfield Relaxation Equation. In 1971 he published experiments that helped to draw the veil of H₂O molecules away from hitherto invisible atoms in large, biological molecules. He continued to innovate specific NMR techniques to view the molecular structure of nucleic acids and enzymes. Beginning in 1996, the NMR Field Cycling community began to realize that slow NMR had an advantage over X-ray crystallography for observing large, biological molecule (macromolecule) dynamics, which can't be captured by high-energy NMR or crystallography. In 1996 he released an article exploring field cycling as a way to study macromolecules in more detail. He published his first article using the phosphorus isotope 31P to probe phospholipids in 2004.
Aside from the conquest of England and the subsequent invasions of Wales and Ireland, the Normans expanded into other areas. Norman families, such as that of Tancred of Hauteville, Rainulf Drengot and Guimond de Moulins played important parts in the conquest of southern Italy and the Crusades. The Drengot lineage, de Hauteville's sons William Iron Arm, Drogo, and Humphrey, Robert Guiscard and Roger the Great Count progressively claimed territories in southern Italy until founding the Kingdom of Sicily in 1130. They also carved out a place for themselves and their descendants in the Crusader states of Asia Minor and the Holy Land.
Sources: en.wikipedia.org
=== Diplomatic relations === After the UDI, Rhodesia maintained several overseas missions, including Pretoria, and until 1975, Lisbon in Portugal and Lourenço Marques (now Maputo) in Mozambique. Since 1961, Rhodesia had an "Accredited Diplomatic Representative" with South Africa, heading a "Rhodesian Diplomatic Mission" or de facto embassy. Before South Africa left the Commonwealth that year, the then Southern Rhodesia had exchanged High Commissioners with the then Union of South Africa, but following the change in status, the Republic now had a "South African Diplomatic Mission" in Salisbury. During 1965, the government of Rhodesia made moves to establish a mission in Lisbon separate from the British Embassy, with its own accredited representative, having previously been able to establish its own consulate in Lourenço Marques, capital of Portuguese Mozambique. This prompted protests from the British government, which was determined that the representative, Harry Reedman, should be a nominal member of the British Ambassador's staff. For their part, the Portuguese authorities sought a compromise whereby they would accept Reedman as an independent representative but deny him diplomatic status. The Rhodesian Information Office in Washington remained open following UDI, but its director, Ken Towsey, and his staff were deprived of their diplomatic status. Previously, there had been a "Minister for Rhodesian Affairs" operating under the aegis of the British Embassy in Washington, as well representatives in Tokyo and Bonn.
There are specific proteins expressed in cardiac muscle cells. These are mostly associated with muscle contraction, and bind with actin, myosin, tropomyosin, and troponin. They include MYH6, ACTC1, TNNI3, CDH2 and PKP2. Other proteins expressed are MYH7 and LDB3 that are also expressed in skeletal muscle.
== Use of snake venoms to treat disease == Given that snake venom contains many biologically active ingredients, some may be useful to treat disease. For instance, phospholipases type A2 (PLA2s) from the Tunisian vipers Cerastes cerastes and Macrovipera lebetina have been found to have antitumor activity. Anticancer activity has been also reported for other compounds in snake venom. PLA2s hydrolyze phospholipids, thus could act on bacterial cell surfaces, providing novel antimicrobial (antibiotic) activities. The analgesic (pain-killing) activity of many snake venom proteins has been long known. The main challenge, however, is how to deliver protein to the nerve cells: proteins usually are not applicable as pills.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Cardarine targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not bind the androgen receptor in the way SARMs do.